High prevalence of strongyloidiasis in spain : A hospital-based study
Requena-Méndez, A. (Karolinska Institutet (Estocolm, Suècia))
Salas-Coronas, J. (Hospital de Poniente (Almería))
Salvador, Fernando (Hospital Universitari Vall d'Hebron)
Gómez-Junyent, Joan (Hospital Universitari de Bellvitge)
Villar-Garcia, Judith (Hospital del Mar (Barcelona, Catalunya))
Santin, Miguel (Hospital Universitari de Bellvitge)
Muñoz-Batet, Carmen (Institut d'Investigació Biomèdica Sant Pau)
González-Cordón, Ana (Hospital Clínic i Provincial de Barcelona)
Fernández, M.T.C. (Hospital de Poniente (Almería))
Sulleiro Igual, Elena (Hospital Universitari Vall d'Hebron)
Arenas-Miras, Maria del Mar (Hospital del Mar (Barcelona, Catalunya))
Somoza, Dolors (Hospital Universitari de Bellvitge)
Vazquez-Villegas, J. (Tropical Medicine Unit. Distrito Poniente)
Treviño, Begoña (Hospital Universitari Vall d'Hebron)
Rodríguez, E. (Centro Nacional de Microbiología (Espanya))
Valls, Maria Eugenia (Hospital Clínic i Provincial de Barcelona)
Llaberia-Marcual, Jaume (Institut d'Investigació Biomèdica Sant Pau)
Subirà, Carme (Hospital Clínic i Provincial de Barcelona)
Muñoz Gutiérrez, José (Hospital Clínic i Provincial de Barcelona)
Universitat Autònoma de Barcelona

Date:	2019
Abstract:	Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. The overall seroprevalence of S. stercoralis was 9. 04% (95%CI 7. 76-10. 31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9. 35% (95%CI 7. 01-11. 69), 9. 22% (7. 5-10. 93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2. 9% (95%CI -0. 3-6. 2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5. 64%) compared with other units of the hospital (10. 20%) or Tropical diseases units (13. 33%) (p < 0. 001). We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Migrants ; Prevalence ; Spain ; Strongyloides stercoralis ; Strongyloidiasis
Published in:	Pathogens, Vol. 9 Núm. 2 (2019) , p. 107, ISSN 2076-0817

DOI: 10.3390/PATHOGENS9020107
PMID: 32053864

13 p, 740.4 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles